CELLGENTEK Co., Ltd announced a private placement of series 3 non-guaranteed private convertible bonds for gross proceeds of KRW 1,500,000,000 on September 25, 2023
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
600 KRW | +9.09% |
|
+1.69% | -79.24% |
2023 | CELLGENTEK Co., Ltd. announced that it has received KRW 1.27795162 billion in funding | CI |
2023 | CELLGENTEK Co., Ltd. announced that it expects to receive KRW 1.27795162 billion in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-79.24% | 1.7M | |
+37.37% | 399B | |
+35.56% | 237B | |
+14.15% | 166B | |
+21.12% | 61.87B | |
+33.29% | 38.34B | |
+1.16% | 29.93B | |
+102.93% | 22.73B | |
+28.99% | 21.69B | |
+40.53% | 14.25B |
- Stock Market
- Equities
- A258250 Stock
- News CELLGENTEK Co., Ltd.
- CELLGENTEK Co., Ltd. announced that it expects to receive KRW 1.5 billion in funding